Background Angiotensin-converting enzyme (ACE) inhibitor use is presumed to be
contraindicated in patients with aortic stenosis (AS). We determined the hemodynamic …

Aims Angiotensin-converting enzyme (ACE) inhibitors improve left ventricular (LV)
remodelling and outcome in heart failure and hypertensive heart disease. They may be …

Background In patients with severe aortic stenosis (AS), treatment with angiotensin-
converting enzyme inhibitors has previously been considered contraindicated. However …

BACKGROUND: Animal models have demonstrated a benefit of angiotensin-converting
enzyme inhibitors (ACEI) in experimental aortic stenosis (AS), and intravenous nitroprusside …

It is almost unknown which demographic factors or medications affect the progression of
aortic stenosis (AS) in Japanese patients with mild AS. We identified a total of 194 patients …

Conventionally angiotensin-converting enzyme (ACE) inhibitors are contraindicated in
patients with aortic stenosis. Abundant evidence is now available showing that angiotensin II …

Objective: To determine the effects of angiotensin converting enzyme (ACE) inhibitors in
hypertensive patients with aortic valve stenosis (AS). Design: Observational, drug …

OBJECTIVES The primary objective of this study was to investigate the effects of the
angiotensin-converting enzyme (ACE) inhibitor, ramipril, on carotid atherosclerosis in …

Background—The added benefits of angiotensin II type I receptor (AT1) blockers (ARBs) to
ACE inhibition suggests that recommended doses of ACE inhibitors provide only partial …

Objectives: The purpose of this study was to investigate the impact of renin-angiotensin
system blockade therapy on outcomes in aortic stenosis (AS). Background: Angiotensin …